Total investments 11
Average round size 
$42M
The average size of a deal this fund participated in
Portfolio companies 9
Lead investments 0
Follow on index
0.18How often the fund supports its portfolio startups at next rounds
Key employees 2
Hasselt, Limburg, Belgium Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bioqube Ventures:
Typical Co-investors
Bioqube Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bioqube Ventures:
There are no funds here. If we find new data, we will add it here.
Funds with similar focus
Funds from Belgium
Funds with similar focus located in Belgium:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Argosy Capital | Pennsylvania, United States, Wayne |
| CITIC Trust | Beijing, Beijing, China |
| Crescendo Venture Partners | Israel, Tel Aviv, Tel Aviv |
| Cutback Ventures | Bayern, Germany, München |
| Daikin Industries, Ltd. | - |
| Divine Capital Markets | New York, New York, United States |
| Krungsri Finnovate | Bangkok, Krung Thep, Thailand |
| Max Giant Capital | China, Hong Kong, Hong Kong Island |
| McRock Capital | Canada, Ontario, Toronto |
| MGI Securities | Canada, Montréal, Quebec |
| Pangea's Edge Holdings | Carrollton, Texas, United States |
| Penna & Company | - |
| Planet Japan | Japan, Tokyo |
| RONAholdings | California, San Francisco, United States |
| Safaricom Foundation | Kenya, Nairobi, Nairobi |
| The Lawrence J. Ellison Revocable Trust | California, United States, Walnut Creek |
| The Pyle Group | Madison, United States, Wisconsin |
| Westerwelle Young Founders Programme | Berlin, Berlin, Germany |
| Yangzi Xinrui | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Commit Biologics | $18M | 09 May 2024 | Aarhus, Midtjylland, Denmark | ||
SynOx Therapeutics | $75M | 22 Apr 2024 | Dublin, Dublin, Ireland | ||
Anavo Therapeutics | $10M | 02 May 2023 | Leiden, South Holland, Netherlands | ||
Bicara Therapeutics | $108M | 06 Mar 2023 | Cambridge, Massachusetts, United States | ||
Enhanc3D Genomics | $13M | 20 Oct 2022 | Cambridge, Massachusetts, United States | ||
Egle Therapeutics | $47M | 22 Oct 2021 | Paris, Ile-de-France, France | ||
Anavo Therapeutics | $23M | 22 Apr 2021 | Leiden, South Holland, Netherlands | ||
Primmune Therapeutics | $4M | 12 Jan 2021 | San Diego, California, United States | ||
Enhanc3D Genomics | 01 Jan 2021 | Cambridge, Massachusetts, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Bioqube Ventures?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 11
Average round size 42M
Peak activity year 2021
Lead investments 0
Follow on index 0.18
Group Appearance index 0.91
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Commit Biologics | $18M | 09 May 2024 | Aarhus, Midtjylland, Denmark | ||
SynOx Therapeutics | $75M | 22 Apr 2024 | Dublin, Dublin, Ireland | ||
Anavo Therapeutics | $10M | 02 May 2023 | Leiden, South Holland, Netherlands | ||
Bicara Therapeutics | $108M | 06 Mar 2023 | Cambridge, Massachusetts, United States | ||
Enhanc3D Genomics | $13M | 20 Oct 2022 | Cambridge, Massachusetts, United States | ||
Egle Therapeutics | $47M | 22 Oct 2021 | Paris, Ile-de-France, France | ||
Anavo Therapeutics | $23M | 22 Apr 2021 | Leiden, South Holland, Netherlands | ||
Primmune Therapeutics | $4M | 12 Jan 2021 | San Diego, California, United States | ||
Enhanc3D Genomics | 01 Jan 2021 | Cambridge, Massachusetts, United States |
